Atlas Trials

Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease

Clinical trial NCT07060547 · RECRUITING

Trial details

NCT number
NCT07060547
Sponsor
HepQuant, LLC
Status
RECRUITING
Study type
OBSERVATIONAL
Alcoholic HepatitisAlcohol-related Liver Disease
Start date
2025-06-10
Primary completion
2031-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.